Benitec Biopharma Incis A Clinical Stage Biotechnology Company Based In Haywardcaliforniafounded In 1995The Company Specializes In Developing Innovative Genetic Medicines That Combine Gene Therapy With Rna Interferencernaitechnologythis Unique Approach Aims To Address Chronic And Life Threatening Diseases The Company S Primary Focus Is On Its Dna Directed Rna Interferenceddrnaitherapeuticstheir Lead Programbb 301Is An Adeno Associated Virusaavbased Gene Therapy Targeting Oculopharyngeal Muscular Dystrophyopmd Bb 301 Is Designed To Permanently Silence The Gene Responsible For Opmd While Delivering A Normal Gene To Restore Functionbenitec Biopharma S Ddrnai Platform Utilizes Dna Templates To Create Short Hairpin Rnasshrnasthat Silence Harmful Genesand This Technology Is Exclusively Licensed From The Commonwealth Scientific And Industrial Research Organisationcsirobenitec Biopharma Collaborates With Partners Like Biomics Biotechnologies To Develop Treatments For Various Diseasesincluding Hepatitis Bthe Company Is Publicly Traded On Nasdaq Under The Ticker Symbol Bntc And Has A Small Team Of Around 16 Employeesjerel Banks Serves As The Ceo
